Clinuvel have never given a trading update and refuse to provide guidance despite knowing most of the patients by name.
There are 2 reasons for this. Firstly, any prediction on timelines, promised updates etc have never been delivered with any accuracy. Secondly, they hate shareholders.
- Forums
- ASX - By Stock
- CUV
- Ann: CLINUVEL renews share buy-back program
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
1.02%
!
$9.66

Ann: CLINUVEL renews share buy-back program, page-46
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$9.66 |
Change
-0.100(1.02%) |
Mkt cap ! $486.1M |
Open | High | Low | Value | Volume |
$9.58 | $9.90 | $9.44 | $948.6K | 97.77K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 252 | $9.67 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.69 | 336 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 226 | 9.710 |
2 | 185 | 9.700 |
2 | 1054 | 9.690 |
1 | 56 | 9.680 |
2 | 106 | 9.670 |
Price($) | Vol. | No. |
---|---|---|
9.720 | 309 | 6 |
9.730 | 118 | 4 |
9.740 | 131 | 5 |
9.750 | 141 | 4 |
9.760 | 10746 | 4 |
Last trade - 15.04pm 18/06/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online